Two-Year Outcomes and Interictal Burden After Treatment for Medication Overuse Headache
Journal of Clinical Medicine · 19.06.2026 · 15 (12) · 4785
DOI: 10.3390/jcm15124785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.06.2026. Verfasst von Yooha Hong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, 7, Keunjaebong-gil, Hwaseong 18450, Gyeonggi-do, Repub…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hallym University.
Abstract (Originalsprache)
Background/Objective: Medication overuse headache (MOH) is a disabling secondary headache disorder that arises from an underlying primary headache, most commonly migraine. Although treatment reduces headache frequency and medication overuse, the interictal burden—the impact experienced between headache attacks—remains poorly characterized over the long term. This study evaluated interictal burden and clinical outcomes two years after MOH diagnosis.
Methods
This study was derived from a prospective multicenter cohort of patients with MOH, using data from a single center. Of 149 patients enrolled between April 2020 and November 2022, 117 (78.5%) completed the two-year follow-up. Clinical characteristics, medication overuse, monthly headache days, and standardized questionnaires were assessed at baseline and follow-up. Interictal burden was evaluated at two years using the Migraine Interictal Burden Scale (MIBS-4), with scores ≥5 indicating severe burden.
Results
At baseline, patients (81.2% female; median age, 45.0 years) reported a median of 16.0 monthly medication days (interquartile range, 13.0–23.0). Medication overuse decreased from 100% at baseline to 24.2% at one year and 17.1% at two years. Among 117 patients with available two-year MIBS-4 data, 25 (21.4%) had severe interictal burden. Compared with those without severe burden, these patients had greater headache-related impact and disability (HIT-6: 68.0 vs. 64.0, p = 0.019; MIDAS: 110.0 vs. 36.0, p = 0.002), higher psychological burden (PHQ-9: 11.0 vs. 8.0, p = 0.032; GAD-7: 7.0 vs. 4.0, p = 0.010), and were more likely to be current smokers (20.0% vs. 4.3%, p = 0.036). Notably, 14.4% of patients with resolved medication overuse still reported severe interictal burden.
Conclusions
Two years after MOH diagnosis, severe interictal burden was observed in a substantial proportion of patients and was associated with greater baseline disability and psychological distress. These findings highlight the need for long-term monitoring and management beyond initial medication withdrawal.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, 7, Keunjaebong-gil, Hwaseong 18450, Gyeonggi-do, Republic of Korea.
ORCID-Profile: Yooha Hong, Mi-Kyoung Kang, Soo-Jin Cho
Förderung
- Hallym University
Zitieren
APA
Hong, Y., Kang, M. K., & Cho, S. J. (2026). Two-Year Outcomes and Interictal Burden After Treatment for Medication Overuse Headache. Journal of Clinical Medicine, 15(12), 4785. https://doi.org/10.3390/jcm15124785
Vancouver
Hong Y, Kang MK, Cho SJ. Two-Year Outcomes and Interictal Burden After Treatment for Medication Overuse Headache. Journal of Clinical Medicine. 2026;15(12):4785. doi:10.3390/jcm15124785
BibTeX
@article{Hong2026,
author = {Hong, Yooha and Kang, Mi-Kyoung and Cho, Soo-Jin},
title = {Two-Year Outcomes and Interictal Burden After Treatment for Medication Overuse Headache},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4785},
doi = {10.3390/jcm15124785}
}
EUVIMED